Results 71 to 80 of about 27,203 (237)

Coccidioidomycosis Prophylaxis in Liver, Kidney, and Heart Transplant Recipients Residing in Endemic Areas Within the United States

open access: yesTransplant Infectious Disease, EarlyView.
Our data suggests that abdominal organ transplant recipients residing in CM‐endemic areas with no prior CM exposure may not require CM prophylaxis. Therefore, we recommend implementing a shared decision‐making model among healthcare providers and patients for this lower‐risk patient population.
Faiza Morado   +5 more
wiley   +1 more source

The Role of Plasmapheresis in the Management of Severe Rhesus Incompatibility During Pregnancy: A Literature Review

open access: yesReproductive, Female and Child Health
Introduction To evaluate the effectiveness and safety of plasmapheresis in cases complicated by severe alloimmunization. Methods We reviewed multiple studies from databases like Medline, Embase, and Cochrane, looking specifically for research on ‘Rhesus ...
Wael Abdallah   +2 more
doaj   +1 more source

Use of immunoglobulin G homeostatic set point and recovery time in plasmapheresis donor safety monitoring: A retrospective observational cohort study

open access: yesVox Sanguinis, EarlyView.
Abstract Background and Objectives Serum immunoglobulin G (IgG) and total protein are used to monitor plasmapheresis donor safety. However, there is a lack of information from large donor cohorts to determine the best use of these measurements. Materials and Methods We identified 230,144 plasmapheresis donors making their first donation between 1 July ...
Janet V. Warner   +4 more
wiley   +1 more source

Effects of Intensive Plasmapheresis on Normal Blood Donors [PDF]

open access: bronze, 1964
Allan Kliman   +3 more
openalex   +1 more source

A relational approach to understanding the factors influencing new plasma donor retention in Canada

open access: yesVox Sanguinis, EarlyView.
Abstract Background and Objectives Understanding the experiences and perceptions of new plasma donors is important for developing strategies to retain them. Materials and Methods This qualitative study focuses on new donors' experiences with plasma donation, the factors that influence their interest in donating again and their thoughts about ...
Morgan Seeley   +2 more
wiley   +1 more source

Increased serum NfL and GFAP levels indicate different subtypes of neurologic immune‐related adverse events during treatment with immune checkpoint inhibitors

open access: yesInternational Journal of Cancer, Volume 156, Issue 10, Page 1961-1971, 15 May 2025.
What's new? Neurological immune‐related adverse events from immune checkpoint inhibitor therapy are rare, but potentially life‐threatening. Here, the authors identified serum neurofilament light chain (NfL) and GFAP, an astrocyte activation marker, as promising biomarkers.
Christina Schmitt   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy